Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19
Ziad Bakouny(Dana-Farber Cancer Institute), Matthew Puc(Virtua Health), Brandon Hayes‐Lattin(Oregon Health & Science University), Daniel Flora(St. Elizabeth Healthcare), Saif Alimohamed(Cincinnati Children's Hospital Medical Center), Shilpa Gupta(Cleveland Clinic), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Taylor K. Nonato(University of California San Diego), Margaret E. Gatti‐Mays(National Cancer Institute), Leslie A. Fecher(University of Pennsylvania), Douglas B. Johnson(Vanderbilt University Medical Center), Lauren Pomerantz(Penn State Milton S. Hershey Medical Center), Andrew J. Portuguese(University of Washington), Cecilia A. Castellano(Emory University), Monika Joshi(Pennsylvania State University), Vadim S. Koshkin(UCSF Helen Diller Family Comprehensive Cancer Center), Chinmay Jani(Mount Auburn Hospital), Joy Awosika(University of Cincinnati), Chih–Yuan Hsu(Vanderbilt University Medical Center), Nora L. Nock(Lucian Blaga University of Sibiu), Punita Grover(University of Cincinnati), Arielle Elkrief(Centre Hospitalier de l’Université de Montréal), Destie Provenzano(George Washington University), Clara Hwang(Henry Ford Health System), Mehmet Asım Bilen(Emory Healthcare), Shuchi Gulati(Comprehensive Blood & Cancer Center), Dharmesh Gopalakrishnan(Roswell Park Comprehensive Cancer Center), Rana R. McKay(University of California San Diego), Sanjay Mishra(Vanderbilt University Medical Center), Roman Jandarov(University of Cincinnati), Babar Bashir(Thomas Jefferson University), Stephanie Berg(Loyola University Medical Center), Amanda Nizam(Cleveland Clinic), Emily Hsu(University of Connecticut), Daniel H. Kwon(Harvard University), Aakash Desai(University of Connecticut), Natalie Knox(Public Health Agency of Canada), Alicia Gesenhues(St. Elizabeth Healthcare), Justin Panasci(McGill University Health Centre), Omar Eton(Hartford Hospital), Daniel W. Bowles(University of Colorado Denver), Mohamed Hendawi(Aurora Health Care), Feras A. Moria(McGill University Health Centre), Þorvarður R. Hálfdánarson(Mayo Clinic), Shaheer Khan(Columbia University Irving Medical Center), Michael Glover(Stanford University), Sara Matar(MUSC Hollings Cancer Center), Amit Kulkarni(University of Minnesota), Hina Khan, Chris Labaki(Beth Israel Deaconess Medical Center)
Cited by 63
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
|The Lancet|2016|2.2k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k